Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Herbalife Pushes To Counter Pyramid Scheme Narrative

This article was originally published in The Tan Sheet

Executive Summary

The multilevel marketer of weight-management shakes and other nutritionals says its independent distributor network, far from being a pyramid scheme, in fact is essential in helping people lose weight and adopt healthy lifestyles, according to Herbalife executives.

You may also be interested in...



Herbalife Turning A New Leaf While An Old Opponent Folds His Tent

Direct seller Herbalife has a new capital allocation strategy and will ask shareholders for a new name and two-for-one split of its stock. It also has lost an old opponent as hedge fund manager and activist investor William Ackman sheds his investment that would have paid off if Herbalife had gone under.

Herbalife Sales Soar, But Firm Confronts Renewed Scrutiny

CEO William Johnson says the firm had “another record performance of double-digit growth while under the constant and unrelenting attack” by activist investor William Ackman. Herbalife executives have met with Sen. Edward Markey’s staff and say they have answered the questions he asked in a January letter.

Herbalife Sales Soar, But Firm Confronts Renewed Scrutiny

CEO William Johnson says the firm had “another record performance of double-digit growth while under the constant and unrelenting attack” by activist investor William Ackman. Herbalife executives have met with Sen. Edward Markey’s staff and say they have answered the questions he asked in a January letter.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS106491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel